WITHDRAWN: Modulation on gallbladder carcinoma by TGF-β1 via IGFBP-2

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Gallbladder carcinoma (GC) has a poor prognosis due to late diagnosis.
• Transformation growth factor-beta (TGF-β) is implicated in GC, but its precise mechanism is unknown.
• Understanding TGF-β's role is crucial for developing effective GC treatments.

Purpose of the Study:

• To investigate the effect and mechanism of TGF-β in gallbladder carcinoma (GC) using the NOZ cell line.
• To elucidate the role of TGF-β1 in GC cell proliferation, invasion, and epithelial-mesenchymal transition (EMT).

Main Methods:

• NOZ cells were transfected with TGF-β1 siRNA to suppress TGF-β1 expression.
• Assays included Real-time PCR, MTT assay, Western blot, and ELISA to measure gene/protein expression and cell activity.
• Evaluated TGF-β1 expression, cell proliferation, apoptosis, invasion, EMT markers, and signaling pathway phosphorylation (p38, Smad2/3, Smad4).

Main Results:

• Suppression of TGF-β1 inhibited NOZ cell proliferation and invasion.
• TGF-β1 inhibition enhanced Caspase-3 activity, indicating increased apoptosis.
• E-cadherin increased, while Vimentin, IGFBP-2, and phosphorylation of p38, Smad2/3, and Smad4 decreased, suggesting reduced EMT.

Conclusions:

• Inhibition of TGF-β1 expression is a promising strategy to combat gallbladder carcinoma (GC).
• Targeting TGF-β1 can facilitate GC cell apoptosis and inhibit proliferation, invasion, and EMT.
• This study provides mechanistic insights into TGF-β1's role in GC progression.